| Prognostic and predictive role of JWA and XRCC1 expression in gastric cancer. | |
| | |
MedLine Citation:
|
PMID: 22452940 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: To investigate the expression pattern and significance of DNA repair genes JWA and XRCC1 in gastric cancer. EXPERIMENTAL DESIGN: Expressions of JWA and XRCC1 were assessed by immunohistochemistry in a training cohort and they went into a second testing cohort and finally to a validating cohort. Prognostic and predictive role of JWA and XRCC1 expression status in cases treated with surgery alone or combined with adjuvant chemotherapy was evaluated, respectively. RESULTS: JWA and XRCC1 protein levels were significantly downregulated in gastric cancer lesions compared with adjacent non-cancerous tissues. Low tumoral JWA or XRCC1 expression significantly correlated with shorter overall survival (OS), as well as with clinicopathologic characteristics in patients without adjuvant treatment. Multivariate regression analysis showed that low JWA and XRCC1 expression, separately and together, were independent negative markers of OS. Adjuvant fluorouracil-leucovorin-oxaliplatin (FLO) significantly improved OS compared with surgery alone (log-rank test, P = 0.01). However, this effect was evident only in the JWA or XRCC1 low expression group (HR = 0.44; 95% CI = 0.26-0.73; P = 0.002, and HR = 0.44; 95% CI = 0.26-0.75; P = 0.002, respectively); Adjuvant fluorouracil-leucovorin-platinol (FLP) did not improve OS, except in the patients with low JWA and XRCC1expression (P = 0.010 for JWA and P = 0.024 for XRCC1, respectively). CONCLUSIONS: JWA and XRCC1 protein expression in tumor are novel candidate prognostic markers and predictive factors for benefit from adjuvant platinum-based chemotherapy (FLO or FLP) in resectable human gastric carcinoma. |
| | |
Authors:
|
Shouyu Wang; Xuming Wu; Yansu Chen; Jingjing Ding; Yan Zhou; Yongfei Tan; Jianbing Zhang; Jin Bai; Jinyan Zeng; Zhenghua Gong; Aiping Li; Gang Li; Oluf Dimitri Roe; Song He; Fulin Qiang; Jianwei Zhou |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-27 |
Journal Detail:
|
Title: Clinical cancer research : an official journal of the American Association for Cancer Research Volume: - ISSN: 1078-0432 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502500 Medline TA: Clin Cancer Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Molecular Cell Biology & Toxicology, School of Public Health, Nanjing Medical University. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic microR...
Next Document: Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathological featur...